Earnings History Data for Biohaven Pharmaceutical Holding Company Ltd. (BHVN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Biohaven Pharmaceutical Holding Company Ltd.

Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company's pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
05-08-2022 PM BHVN Biohaven Pharmaceutical 10,309 -6.21 -2.79 0.00 Biohaven Pharmaceuticals Non-GAAP EPS of -$3.82 misses by $1.57, revenue of $194M misses by $16.6M
[8/5/2022 7:24 AM]
146.98 -0.12 
(-0.08%)
146.98 0.0 
(0.00%)
79.01 - 151.51 309,512 590,000 978
10-05-2022 PM 7:00 AM ET
(May 11)
BHVN Biohaven Pharmaceutical Holding Company Ltd. 6,840 -2.97 -2.52 -4.21 Biohaven Pharmaceuticals Non-GAAP EPS of -$1.62 beats by $0.65, revenue of $318.85M beats by $135.14M
[5/10/2022 7:01 AM]
141.00 57.86 
(69.59%)
141.40 58.26 
(70.07%)
65.24 - 151.51 15,907,814 677,623 1,479,452
25-02-2022 PM 7:45 AM ET
(Feb 25)
BHVN Biohaven Pharmaceutical Holding Company Ltd. 8,780 -3.01 -2.07 -3.62 Biohaven Pharmaceuticals Non-GAAP EPS of -$2.32 misses by $0.39, revenue of $190.01M beats by $14.47M
[2/25/2022 7:49 AM]
121.98 -11.83 
(-8.84%)
136.00 2.19 
(1.64%)
62.57 - 151.51 780,432 440,000 4,024
09-11-2021 PM 7:00 AM ET
(Nov 9)
BHVN Biohaven Pharmaceutical Holding Company Ltd. 9,680 -2.63 -2.44 -3.27 Biohaven Pharmaceuticals EPS beats by $0.11, beats on revenue
[11/9/2021 8:33 AM]
121.58 -18.18 
(-13.01%)
118.00 -21.77 
(-15.58%)
62.57 - 151.51 2,538,376 260,000 105,911
09-08-2021 PM 7:30 AM ET
(Aug 9)
BHVN Biohaven Pharmaceutical Holding Company Ltd. 8,240 -3.23 -2.77 -2.55 Biohaven Pharmaceuticals EPS misses by $0.38, beats on revenue
[8/9/2021 9:45 AM]
118.00 -6.54 
(-5.25%)
125.50 0.96 
(0.77%)
57.66 - 132.91 626,289 540,000 6,935
10-05-2021 PM 7:30 AM ET
(May 10)
BHVN Biohaven Pharmaceutical Holding Company Ltd. 4,570 -4.21 -2.99 -2.39 Biohaven Pharmaceuticals EPS misses by $0.37, beats on revenue
[5/10/2021 7:52 AM]
69.32 -2.12 
(-2.97%)
69.90 -1.54 
(-2.16%)
42.74 - 100.77 710,327 410,000 1,234
01-03-2021 PM 8:00 AM ET
(Mar 1)
BHVN Biohaven Pharmaceutical Holding Company Ltd. 5,000 -3.62 -2.89 -2.85 Biohaven Pharmaceuticals EPS misses by $0.13, beats on revenue
[3/1/2021 8:32 AM]
86.50 1.52 
(1.79%)
85.30 0.32 
(0.38%)
26.56 - 100.77 370,262 502,575 260
09-11-2020 PM 7:45 AM ET
(Nov 9)
BHVN Biohaven Pharmaceutical Holding Company Ltd. 5,240 -3.27 -2.74 -2.04 Biohaven Pharmaceuticals EPS beats by $0.19, misses on revenue
[11/9/2020 8:03 AM]
81.38 -1.02 
(-3.48%)
84.25 -0.06 
(-0.07%)
26.56 - 89.46 1,072,719 565,257 221
10-08-2020 PM Before the open
(Aug 10)
BHVN Biohaven Pharmaceutical Holding Company Ltd. 3,710 -2.55 -2.78 -2.35 Biohaven Pharmaceuticals EPS beats by $0.29, beats on revenue
[8/10/2020 7:47 AM]
63.33 2.35 
(-6.39%)
70.00 2.35 
(3.47%)
26.56 - 78.75 532,876 580,031 704